Web
|
Images
|
News
News Home
US
World
Business
Finance
Industry
Technology
Science
Media & Advertising
Politics/Law
Entertainment
Internet
Health
Sports
Culture
MORTGAGE INDUSTRY
Log In
Micromet Axes Alliance with MedImmune Regaining Rights to Clinical-Stage Cancer
Have an interest in this Story?
Sign Up for Real-Time email updates
Genetic Engineering News
|
November 05, 2009
Micrometis buying out MedImmuneâ??s option to blinatumomab in North America and is terminating their collaboration, which began in 2003. Micromet also regains MedImmuneâ??s rights to any other bi-specific T-cell engager (BiTE) antibodies binding to antigens relevant for hematological cancers that ha...
Read Full Article
Leave a Comment:
You must be logged in to leave a comment
Log in
|
Register
Most Read World Articles
Switzerland votes on the building of minarets
- Kazakhstan News
Exit polls show Swiss will accept minaret ban: TV (AFP)
- AFP via Yahoo!
Saudi floods death toll hits 83 as Hajj continues
- Al Arabiya
Griffin in EU climate delegation
- Evening Gazette
Goldsmith 'expressed doubt' on Iraq
- Filey Mercury
Featured Members
Matthew Clark
Mentor
Entrepreneur
Rama Sethu Ranga Nathan
Consultant Sound/Recording Engineer
Music Industry
View more profiles
Access dozens of premium and subscriptions sites
Free!
Download now
.
Advertise
|
Build a News Circle
|
Get News Briefings
|
Congoo News Home
|
Get the Netpass
About Congoo
|
Terms
|
Privacy
|
Need Help?
|
Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.